These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20923030)

  • 61. [Prevalence of hypertension among young people and efficacy of its treatment with enalapril].
    Bazina IB
    Kardiologiia; 2002; 42(5):23-5. PubMed ID: 12494143
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension Group.
    Chrysant SG; Gavras H; Niederman AL; Marbury TC; Goldstein R
    J Clin Pharmacol; 1997 Sep; 37(9):810-5. PubMed ID: 9549634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypertension: an ACCOMPLISHED regimen for hypertension.
    Turnbull F
    Nat Rev Nephrol; 2009 Apr; 5(4):183-4. PubMed ID: 19322179
    [No Abstract]   [Full Text] [Related]  

  • 64. Antihypertensive agents: are all of them equal?
    Barrios V; Escobar C
    South Med J; 2008 Aug; 101(8):779-80. PubMed ID: 18622351
    [No Abstract]   [Full Text] [Related]  

  • 65. [Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg].
    Marín-Iranzo R; de la Sierra-Iserte A; Roca-Cusachs A; Oliván-Martínez J; Redón-Mas J; Luque-Otero M; de la Figuera-von Wichman M; Pontes-García C; Delgadillo-Duarte J;
    Rev Clin Esp; 2005 Sep; 205(9):418-24. PubMed ID: 16194475
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Experience and comparison of antihypertensive effect of ace inhibitor spirapril and calcium antagonist amlodipinein standard and chronotherapeutic prescription mode].
    Ovchan HO; Khomenko VM; Andrushko II; Ostapchuk OI; Kyrychenko LM
    Wiad Lek; 2017; 70(4):721-724. PubMed ID: 29064793
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiovascular endocrinology: tailoring antihypertensive drug treatment to body size.
    Grassi G; Mancia G
    Nat Rev Endocrinol; 2013 Mar; 9(3):141-3. PubMed ID: 23381028
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of enalapril injected in the early period of postnatal ontogeny on structure of adrenal glands in mature hypertensive NISAG rats.
    Buzueva II
    Bull Exp Biol Med; 2006 Feb; 141(2):175-7. PubMed ID: 16984089
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Kyphoscoliosis as a cause of pulmonary hypertension].
    Schröder A; Schumacher T; Tromm A
    Med Klin (Munich); 2003 Feb; 98(2):100-3. PubMed ID: 12601535
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chronopharmacologic considerations when treating the patient with hypertension: a review.
    Straka RJ; Benson SR
    J Clin Pharmacol; 1996 Sep; 36(9):771-82. PubMed ID: 8889897
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypertension and reduced renal function in an 83-year-old patient.
    Ungar A; Lambertucci L; Agresti C; Pini R; Boddi M; Valentini MC; Parati G; Modesti PA
    Intern Emerg Med; 2006; 1(1):40-8. PubMed ID: 16941812
    [No Abstract]   [Full Text] [Related]  

  • 72. Papilledema in a Hypertensive Adult With Grade 4 Retinopathy.
    Akal A; Adibelli MF; Karakas EY; Ulas T
    J Clin Hypertens (Greenwich); 2015 Sep; 17(9):740. PubMed ID: 25884103
    [No Abstract]   [Full Text] [Related]  

  • 73. Compliance in an anti-hypertension trial: a latent process model for binary longitudinal data.
    Smith DM; Diggle PJ
    Stat Med; 1998 Feb; 17(3):357-70. PubMed ID: 9493259
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of pharmacokinetic modelling and computer simulation in drug formulation design.
    Grabnar I; Belic A; Mrhar A; Karba R
    Comput Biol Med; 1998 Jul; 28(4):365-76. PubMed ID: 9805197
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Isolated systolic hypertension].
    Scholze J
    MMW Fortschr Med; 2009 Sep; 151(37):40-1. PubMed ID: 19827426
    [No Abstract]   [Full Text] [Related]  

  • 76. Calcium channel blockers and alpha-blockers in hypertension: what is the evidence?
    Mendis S
    Ceylon Med J; 2000 Dec; 45(4):152-3. PubMed ID: 11293955
    [No Abstract]   [Full Text] [Related]  

  • 77. [Notes on real and daily cost-efficiency].
    Ortega-Marlasca MM
    Semergen; 2014 Mar; 40(2):115. PubMed ID: 24560996
    [No Abstract]   [Full Text] [Related]  

  • 78. Hypertensive crises: emergencies and urgencies.
    Vidt DG
    J Clin Hypertens (Greenwich); 2004 Sep; 6(9):520-5. PubMed ID: 15365281
    [No Abstract]   [Full Text] [Related]  

  • 79. [The correlation of the metabolic link of the activity of the endogenous opiate system in alcoholism].
    Seleznev AG
    Lik Sprava; 1998; (1):148-52. PubMed ID: 9621644
    [No Abstract]   [Full Text] [Related]  

  • 80. Effects of an antihypertensive medication on functional capacity under simulated flight-typical stress-conditions.
    Wolfram G; Drummer C; Helbig R; Hesse C; Klan R; Sittner WD; Baisch F
    Eur J Med Res; 1999 Sep; 4(9):379-81. PubMed ID: 10477504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.